about kinex

Kinex Pharmaceuticals - Buffalo NY Biotechnology Company

Kinex is a global oncology specialty pharmaceutical company focused on the development and commercialization of next generation therapies for cancer and immunomodulatory diseases.

Our Company >>

clinical trials

Kinex Pharmaceuticals Clinical Trials

Kinex has numerous clinical oncology studies underway or in the planning stage.

Clinical Trials >>

News/Events

Kinex Pharmaceuticals Announces First Patient Dosed with KX2-391 Ointment for Actinic Keratosis in a Phase 1 Clinical Study Tuesday, January 20th, 2015

Kinex Pharmaceuticals announced today that the first actinic keratosis patient has been dosed with KX2-391 ointment in Austin, Texas. KX2-391 (KX01), a

Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study Wednesday, December 24th, 2014

Kinex Pharmaceuticals announced today that the first patient has been dosed with KX2-361 at Roswell Park Cancer Institute. KX2-361 (KX02), a dual

News/Events >>